BRAIN TUMOR LIBRARY
Glioblastoma | Follow-up and quality of life
48




Home > Brain tumor library > Diffuse astrocytic and oligodendroglial tumors > Glioblastoma > Follow-up and quality of life



ANTICONVULSANTS



Wali AR, Rennert RC, Wang SG, Chen CC.
Prophylactic anticonvulsants in patients with primary glioblastoma.
J Neurooncol. 2017 Jul 28. doi: 10.1007/s11060-017-2584-8. [Epub ahead of print]

Source | Abstract | Full text | Similar articles



ANTIDEPRESSANTS



Bielecka AM, Obuchowicz E.
Antidepressant drugs can modify cytotoxic action of temozolomide.
Eur J Cancer Care (Engl). 2016 Aug 2. doi: 10.1111/ecc.12551. [Epub ahead of print]
Source | Abstract | Full text | Similar articles





ANTIANGIOGENESIS



Mamo A, Baig A, Azam M, Rho YS, Sahebjam S, Muanza T, Owen S, Petrecca K, Guiot MC, Al-Shami J, Sharma R, Kavan P.
Progression pattern and adverse events with bevacizumab in glioblastoma.
Curr Oncol. 2016 Oct;23(5):e468-e471. Epub 2016 Oct 25.
Source | Abstract | Full text | Similar articles





CHEMOTHERAPY



Desai VCA, Quinlan SC, Deitz AC, He J, Holick CN, Lanes S.
Risk of severe acute liver injury among patients with brain cancer treated with temozolomide: a nested case-control study using the healthcore integrated research database.
J Neurooncol. 2017 Aug;134(1):89-95. doi: 10.1007/s11060-017-2489-6. Epub 2017 Jul 17.
Source | Abstract | Full text | Similar articles





END OF LIFE SIGNS AND SYMPTOMS



Thier K, Calabek B, Tinchon A, Grisold W, Oberndorfer S.
The Last 10 Days of Patients With Glioblastoma: Assessment of Clinical Signs and Symptoms as well as Treatment.
Am J Hosp Palliat Care. 2016 Dec;33(10):985-988. Epub 2015 Oct 14.
Source | Abstract | Full text | Similar articles





PROGRESSIVE VS. RESPONSIVE FORMS



Ion-Mărgineanu A, Van Cauter S, Sima DM, Maes F, Sunaert S, Himmelreich U, Van Huffel S.
Classifying Glioblastoma Multiforme Follow-Up Progressive vs. Responsive Forms Using Multi-Parametric MRI Features.
Front Neurosci. 2017 Jan 11;10:615. doi: 10.3389/fnins.2016.00615.
Source | Abstract | Full text | Similar articles





RADIOTHERAPY



Minniti G, Scaringi C, Baldoni A, Lanzetta G, De Sanctis V, Esposito V, Enrici RM.
Health-related quality of life in elderly patients with newly diagnosed glioblastoma treated with short-course radiation therapy plus concomitant and adjuvant temozolomide.
Int J Radiat Oncol Biol Phys. 2013 Jun 1;86(2):285-91. doi: 10.1016/j.ijrobp.2013.02.013.
Source | Abstract | Full text | Similar articles





RISK OF SUBSEQUENT CANCER



Li X, Li Y, Cao Y, Li P, Liang B, Sun J, Feng E.
Risk of subsequent cancer among pediatric, adult and elderly patients following a primary diagnosis of glioblastoma multiforme: a population-based study of the SEER database.
Int J Neurosci. 2017 Mar 17:1-7. doi: 10.1080/00207454.2017.1288624. [Epub ahead of print]

Source | Abstract | Full text | Similar articles





TUMOR TREATING FIELDS THERAPY



Majd P, O'Connell DE, Kim RC, Bota DA, Carrillo JA.
Case of glioblastoma patient treated with tumor treating fields therapy at recurrence degenerating to sarcoma.
CNS Oncol. 2017 Mar 17. doi: 10.2217/cns-2016-0035. [Epub ahead of print]

Source | Abstract | Full text | Similar articles